p38-MAPK inhibitor TA-02, Purity ≥98%

Synonym: TA-02; 1784751-19-4; TA 02; TA02; 4-[2-(2-Fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine; 4-(2-(2-Fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)pyridine; p38-MAPK inhibitor

MDL: MFCD29924749
CAS Number: 1784751-19-4
Compound CID: 91691130

Product Size

1 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

TA-02, soluble in DMSO and ethanol and insoluble in water, targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates.

Molecular Weight

333.33

Molecular Formula

C₂₀H₁₃F₂N₃

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 66 mg/mL (198 mM); Water: Insoluble; Ethanol: 3 mg/mL (9 mM)

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

TA-02 is applied in research examining its role as a MAP kinase inhibitor, particularly for its effects on neuroinflammatory pathways.

Storage

Store at -20ºC.